Literature DB >> 25277536

Stromal-dependent tumor promotion by MIF family members.

Robert A Mitchell1, Kavitha Yaddanapudi2.   

Abstract

Solid tumors are composed of a heterogeneous population of cells that interact with each other and with soluble and insoluble factors that, when combined, strongly influence the relative proliferation, differentiation, motility, matrix remodeling, metabolism and microvessel density of malignant lesions. One family of soluble factors that is becoming increasingly associated with pro-tumoral phenotypes within tumor microenvironments is that of the migration inhibitory factor family which includes its namesake, MIF, and its only known family member, D-dopachrome tautomerase (D-DT). This review seeks to highlight our current understanding of the relative contributions of a variety of immune and non-immune tumor stromal cell populations and, within those contexts, will summarize the literature associated with MIF and/or D-DT.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cancer; D-DT; Hypoxia; MIF; Stroma; Tumor microenvironment

Mesh:

Substances:

Year:  2014        PMID: 25277536      PMCID: PMC4293307          DOI: 10.1016/j.cellsig.2014.09.012

Source DB:  PubMed          Journal:  Cell Signal        ISSN: 0898-6568            Impact factor:   4.315


  170 in total

Review 1.  CD74: an emerging opportunity as a therapeutic target in cancer and autoimmune disease.

Authors:  Federica Borghese; Felix I L Clanchy
Journal:  Expert Opin Ther Targets       Date:  2011-01-06       Impact factor: 6.902

2.  The MIF homologue D-dopachrome tautomerase promotes COX-2 expression through β-catenin-dependent and -independent mechanisms.

Authors:  Dan Xin; Beatriz E Rendon; Ming Zhao; Millicent Winner; Arlixer McGhee Coleman; Robert A Mitchell
Journal:  Mol Cancer Res       Date:  2010-11-11       Impact factor: 5.852

3.  Macrophage migration inhibitory factor (MIF) sustains macrophage proinflammatory function by inhibiting p53: regulatory role in the innate immune response.

Authors:  Robert A Mitchell; Hong Liao; Jason Chesney; Gunter Fingerle-Rowson; John Baugh; John David; Richard Bucala
Journal:  Proc Natl Acad Sci U S A       Date:  2001-12-26       Impact factor: 11.205

4.  Mechanism of immune dysfunction in cancer mediated by immature Gr-1+ myeloid cells.

Authors:  D I Gabrilovich; M P Velders; E M Sotomayor; W M Kast
Journal:  J Immunol       Date:  2001-05-01       Impact factor: 5.422

5.  Activated granulocytes and granulocyte-derived hydrogen peroxide are the underlying mechanism of suppression of t-cell function in advanced cancer patients.

Authors:  J Schmielau; O J Finn
Journal:  Cancer Res       Date:  2001-06-15       Impact factor: 12.701

6.  Non-small cell lung cancer cells induce monocytes to increase expression of angiogenic activity.

Authors:  E S White; S R Strom; N L Wys; D A Arenberg
Journal:  J Immunol       Date:  2001-06-15       Impact factor: 5.422

7.  Macrophage migration inhibitory factor counterregulates dexamethasone-mediated suppression of hypoxia-inducible factor-1 alpha function and differentially influences human CD4+ T cell proliferation under hypoxia.

Authors:  Timo Gaber; Saskia Schellmann; Kerem B Erekul; Monique Fangradt; Karolina Tykwinska; Martin Hahne; Patrick Maschmeyer; Markus Wagegg; Cindy Stahn; Paula Kolar; René Dziurla; Max Löhning; Gerd-Rüdiger Burmester; Frank Buttgereit
Journal:  J Immunol       Date:  2010-12-17       Impact factor: 5.422

8.  Myeloid-derived suppressor cells in the peripheral blood of cancer patients contain a subset of immature neutrophils with impaired migratory properties.

Authors:  Sven Brandau; Sokratis Trellakis; Kirsten Bruderek; Dominik Schmaltz; Gabriele Steller; Motaz Elian; Henrik Suttmann; Marcus Schenck; Jürgen Welling; Peter Zabel; Stephan Lang
Journal:  J Leukoc Biol       Date:  2010-11-24       Impact factor: 4.962

Review 9.  Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis.

Authors:  A Moretta; C Bottino; M Vitale; D Pende; C Cantoni; M C Mingari; R Biassoni; L Moretta
Journal:  Annu Rev Immunol       Date:  2001       Impact factor: 28.527

10.  The interplay of matrix metalloproteinases, morphogens and growth factors is necessary for branching of mammary epithelial cells.

Authors:  M Simian; Y Hirai; M Navre; Z Werb; A Lochter; M J Bissell
Journal:  Development       Date:  2001-08       Impact factor: 6.868

View more
  9 in total

1.  Human Leukocyte Antigen-Presented Macrophage Migration Inhibitory Factor Is a Surface Biomarker and Potential Therapeutic Target for Ovarian Cancer.

Authors:  Andrea M Patterson; Saghar Kaabinejadian; Curtis P McMurtrey; Wilfried Bardet; Ken W Jackson; Rosemary E Zuna; Sanam Husain; Gregory P Adams; Glen MacDonald; Rachelle L Dillon; Harold Ames; Rico Buchli; Oriana E Hawkins; Jon A Weidanz; William H Hildebrand
Journal:  Mol Cancer Ther       Date:  2015-12-30       Impact factor: 6.261

2.  CXCL2/MIF-CXCR2 signaling promotes the recruitment of myeloid-derived suppressor cells and is correlated with prognosis in bladder cancer.

Authors:  H Zhang; Y-L Ye; M-X Li; S-B Ye; W-R Huang; T-T Cai; J He; J-Y Peng; T-H Duan; J Cui; X-S Zhang; F-J Zhou; R-F Wang; J Li
Journal:  Oncogene       Date:  2016-10-10       Impact factor: 9.867

3.  Identification and Validation of Immune-Related Gene Signature for Predicting Lymph Node Metastasis and Prognosis in Lung Adenocarcinoma.

Authors:  Ran Jia; Zhilin Sui; Hongdian Zhang; Zhentao Yu
Journal:  Front Mol Biosci       Date:  2021-05-24

4.  Hsp90-stabilized MIF supports tumor progression via macrophage recruitment and angiogenesis in colorectal cancer.

Authors:  Luisa Klemke; Tiago De Oliveira; Daria Witt; Nadine Winkler; Hanibal Bohnenberger; Richard Bucala; Lena-Christin Conradi; Ramona Schulz-Heddergott
Journal:  Cell Death Dis       Date:  2021-02-04       Impact factor: 8.469

5.  Exosomal MIF Derived From Nasopharyngeal Carcinoma Promotes Metastasis by Repressing Ferroptosis of Macrophages.

Authors:  Wenhui Chen; Fan Zuo; Kaiwen Zhang; Tian Xia; Wei Lei; Zixiang Zhang; Lili Bao; Yiwen You
Journal:  Front Cell Dev Biol       Date:  2021-12-31

Review 6.  TA-MSCs, TA-MSCs-EVs, MIF: their crosstalk in immunosuppressive tumor microenvironment.

Authors:  Zhenghou Zhang; Xiangyu Zhou; Jinshuai Guo; Fusheng Zhang; Yiping Qian; Guang Wang; Meiqi Duan; Yutian Wang; Haiying Zhao; Zhi Yang; Zunpeng Liu; Xiaofeng Jiang
Journal:  J Transl Med       Date:  2022-07-16       Impact factor: 8.440

Review 7.  Macrophage migration inhibitory factor involvement in breast cancer (Review).

Authors:  Vincent Richard; Nadège Kindt; Sven Saussez
Journal:  Int J Oncol       Date:  2015-09-24       Impact factor: 5.650

8.  Macrophage Migration Inhibitory Factor Secretion Is Induced by Ionizing Radiation and Oxidative Stress in Cancer Cells.

Authors:  Yashi Gupta; Vinay Pasupuleti; Weinan Du; Scott M Welford
Journal:  PLoS One       Date:  2016-01-07       Impact factor: 3.240

9.  Role of MIF/CD74 signaling pathway in the development of pleural mesothelioma.

Authors:  Cintia D'Amato-Brito; Davide Cipriano; Didier J Colin; Stéphane Germain; Yann Seimbille; John H Robert; Frédéric Triponez; Véronique Serre-Beinier
Journal:  Oncotarget       Date:  2016-03-08
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.